ArticleESMO gastrointestinal oncology2026
Clinical implications of zolbetuximab-associated hypoalbuminemia in CLDN18.2-positive gastric or gastroesophageal junction cancer.
A Ooki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.